Johnson & Johnson has announced the FDA’s approval of a first-of-its-kind, esketamine nasal spray called Spravato for the ...
Exploring new treatment avenues has become crucial as mental health challenges such as depression and PTSD continue impacting ...
The synergistic relationship between psychiatric medications and psychotherapy is often overlooked. By managing discreet ...
Management of PTSD may involve the use of various treatment modalities, involving both nondrug treatments and pharmacotherapy. Nondrug treatment is regarded as the first-line option for PTSD and ...
Johnson & Johnson has announced a major breakthrough in mental health treatment. The Food and Drug Administration (FDA) has approved Spravato, a novel nasal spray, for the standalone treatment of ...
We provide a holistic treatment approach that addresses alcohol and drug addiction alongside a wide range of mental health issues like anxiety, depression, bipolar, PTSD, BPD, and more.
for PTSD. Psilocybin, the psychoactive ingredient in hallucinogenic (or ‘magic’) mushrooms, can also be given to those with treatment resistant depression (TRD). The two drugs have now been ...
Because it is still awaiting approval, Medicare does not typically cover the use of ketamine infusion for treating mental ...
TMS safety, accelerated 5-day treatment options, and therapy costs are explained by Inspire TMS Denver. Broomfield, Colorado- ...